Patents for A61P 35 - Antineoplastic agents (221,099)
12/2004
12/15/2004CN1554443A Oral liquid for increasing hemogram, enhancing immunity and inhibiting tumour in cancer radiation and chemical therapy
12/15/2004CN1554430A Chinese medicne for treating liver cancer
12/15/2004CN1554421A Tumour control pill
12/15/2004CN1554358A Dibutyryl cyclic adenosine monophosphate preparation and preparing method
12/15/2004CN1554356A Method for preparing baicalin liquid
12/15/2004CN1554354A Epi-doxorubicine liposome and its preparing method
12/15/2004CN1554351A Medicinal composite preparation including active vitamine d compound and its use
12/15/2004CN1554344A Camptothecine and hydroxy camptothecine lipid composition and its preparing method
12/15/2004CN1554334A Rebescensine A emulsion and its preparing method
12/15/2004CN1554332A Use of Elsinochrome A in preparing anti-cancer medicine
12/15/2004CN1554331A High nurity beta-elemene medicine and its preparing method
12/15/2004CN1179969C European verbena herb extract, and preparing process and use thereof
12/15/2004CN1179968C Scrophularia oligose, production method and use thereof
12/15/2004CN1179960C Indole derivatives and their use for treamtent of osteoporosis amongst other applications
12/15/2004CN1179954C Substd. heterocyclic compounds, preparing process thereof and pharmaceutical composition contg. them
12/15/2004CN1179752C Benzodiazapine compounds containing imidazole propanamido and its preparing process and application
12/15/2004CN1179749C Method for preparing tumor specific transfer factors
12/15/2004CN1179729C Pharmaceutical composition having antitumor activity and process for the preparation thereof
12/15/2004CN1179728C Process for preparing black nightshade extract as anticancer medicine
12/14/2004US6831286 Method for determining a tilt angle of an optical pickup head
12/14/2004US6831199 Pyrimidine compounds and derivatives thereof
12/14/2004US6831196 Such as benzylsulfonyl-D-Ser-Gly-4-amidinobenzylamide, HCl salt; for treatment of malign tumors/metastatic spread
12/14/2004US6831186 Antiinflammatory agents; autoimmune disease
12/14/2004US6831180 Substituted tertiary carboxylic oxacycloalkane acids, used to prepare anhydro-homo-harringtonic acids by semi-synthesis; hydroxyl function of a cephalotaxane is esterified with a 2-carboxyl-2-alkyl-1-oxacycloalkane claimed intermediate; (indexing from 7169774 added)
12/14/2004US6831106 Vitamin D analogues
12/14/2004US6831105 For therapy and prophylaxis of cardiovascular diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders
12/14/2004US6831101 Compounds that bind to one or more RANTES receptors for treatment of chemokine mediated disease states
12/14/2004US6831097 2,3-diaryl-pyrazolo[1,5-B]pyridazines derivatives, their preparation and their use as cyclooxygenase 2 (COX-2) inhibitors
12/14/2004US6831091 Anticancer agents
12/14/2004US6831090 Having microtubule-stabilizing effects and cytotoxic activity against rapidly proliferating cells, such as, tunior cells or other hyperproliferative cellular disease
12/14/2004US6831085 Methods and compositions utilizing quinazolinones
12/14/2004US6831076 Epothilons C and D, preparation and compositions
12/14/2004US6831075 Heterocyclic substituted pyrazolones
12/14/2004US6831069 Pyrrolo[2,3-d]pyrimidine nucleoside analogs
12/14/2004US6831067 Substance having physiological property, method for producing the same and uses thereof
12/14/2004US6831065 Anti-inflammatory compounds and uses thereof
12/14/2004US6831061 Apicidin-derivatives, their synthetic methods and anti-tumor compositions containing them
12/14/2004US6831059 Compositions and methods for treating gonadotrophin related illnesses
12/14/2004US6830924 For anticarcinogenic drugs; kits
12/14/2004US6830894 Compounds and methods for modulating claudin-mediated functions
12/14/2004US6830749 Antitumor agents; gene therapy
12/14/2004CA2296535C Antisense oligonucleotide inhibition of ras
12/14/2004CA2225453C Compounds with chelation affinity and selectivity for first transition series elements, and their use in medical therapy and diagnosis
12/14/2004CA2146320C Antisense oligonucleotide inhibition of the ras gene
12/14/2004CA2104957C Redirection of cellular immunity by receptor chimeras
12/13/2004CA2470935A1 Polyene oxazoles and processes for their preparation
12/09/2004WO2004106938A2 Diagnostics and therapeutics for diseases associated with g protein-coupled p2y purinoreceptor 7 (p2y7)
12/09/2004WO2004106935A2 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 103 (gpr103)
12/09/2004WO2004106934A2 Diagnostics and therapeutics for diseases associated with 5-hydroxytryptamine (serotonin) receptor 7 (5-ht7)
12/09/2004WO2004106917A2 Method for the selection of epitopes for immunotherapy
12/09/2004WO2004106522A1 Gene encoding a ribosome-inactivating protein, known as recombinant musarmin 4, expression in bacterial system, method of obtaining same and applications thereof
12/09/2004WO2004106515A1 Anti-bambi antibody and diagnostic or remedy for colon cancer and liver cancer containing the same
12/09/2004WO2004106511A1 OLIGO DOUBLE-STRANDED RNA INHIBITING THE EXPRESSION OF Bcl-2 AND MEDICINAL COMPOSITION CONTAINING THE SAME
12/09/2004WO2004106505A1 A gutless adenovirus vector and the construction method thereof
12/09/2004WO2004106381A1 Pharmaceutical compositions comprising bispecific anti-cd3, anti-cd19 antibody constructs for the treatment of b-cell related disorders
12/09/2004WO2004106358A1 Target-oriented chemotherapy for treating tumors of the sexual organs
12/09/2004WO2004106356A1 Functionalized nucleotide derivatives
12/09/2004WO2004106343A2 Agelastatin derivatives of antitumour and gsk-3beta-inhibiting alkaloids
12/09/2004WO2004106335A1 Harmine derivatives, intermediates used in their preparation, preparation processes and use thereof
12/09/2004WO2004106321A1 4-aryl-5h-thiophene-2-one derivatives and its preparation and use
12/09/2004WO2004106312A1 Novel 2-aminoselenazoline derivative and use thereof
12/09/2004WO2004106308A1 Quinazolines and pyrido [3,4-d] pyrimidines as receptor tyrosine kinase inhibitors
12/09/2004WO2004106307A2 Novel imidazole derivatives, the production thereof, and the use of the same as a medicament
12/09/2004WO2004106291A1 Haloethyl urea compounds and the use thereof to attenuate, inhibit or prevent cancer cell migration
12/09/2004WO2004106280A1 CaSR ANTAGONIST
12/09/2004WO2004105784A1 Class iii slrp agonists for the reduction of blood vessel formation
12/09/2004WO2004105777A1 Rock flour, especially dolomite-based medicament, for the treatment of cancer diseases
12/09/2004WO2004105776A1 Medicament for internal application, in particular against cancerous diseases
12/09/2004WO2004105765A1 Macrocyclic quinazoline derivatives as antiproliferative agents
12/09/2004WO2004105761A1 Combined use of ecteinascidin-743 and platinum antineoplastic compounds
12/09/2004WO2004105678A2 Pharmaceutical composition based on ketorolac or one of its salts pharmaceutically acceptable and use of ketorolac or its salts in pharmaceutical compositions
12/09/2004WO2004098626A3 The use of a polypeptide domain of slpi to modulate the tumorigenic and metastatic potential of cancer cells
12/09/2004WO2004087699A3 Thiazoles useful as inhibitors of protein kinases
12/09/2004WO2004087698A3 Thiazoles useful as inhibitors of protein kinases
12/09/2004WO2004080922A3 Substituted vitamin d analogues and their therapeutic uses
12/09/2004WO2004060262A3 Modulators of notch signalling for use in immunotherpapy
12/09/2004WO2004058275A3 Compositions of magnetic particles covered with gem-bisphosphonate derivatives
12/09/2004WO2004056874A3 Neuropilin-1 inhibitors
12/09/2004WO2003102588A3 Diagnostic agent, method for detecting a carcinoma, and means for the treatment thereof
12/09/2004WO2003101486A3 Thermosensitive polymer carriers having a modifiable physical structure for biochemical analysis, diagnosis, and therapy
12/09/2004WO2003097051A3 Use of compounds that are effective as selective opiate receptor modulators
12/09/2004WO2003093478A9 Immunoconjugates for the treatment of tumours
12/09/2004WO2003090687A8 Using heat shock proteins to increase immune response
12/09/2004WO2003087131A3 Anti-her2 antibody variants
12/09/2004WO2003080808A3 Novel compositions and methods in cancer
12/09/2004WO2003080582A3 Fredericamycin derivatives
12/09/2004WO2003072114A9 Vascular therapeutics
12/09/2004WO2003062262A3 Modulation of heat-shock-protein-based immunotherapies
12/09/2004WO2003057835A3 Pak5-related compositions and methods
12/09/2004WO2003053219A3 Methods for slowing senescence and treating and preventing diseases associated with senescence
12/09/2004US20040249167 Substituted benzopyrans as selective estrogen receptor-beta agonists
12/09/2004US20040249161 Biphenyl-derivatives as p38-kinase inhibitors
12/09/2004US20040249158 Amine salts of an integrin receptor antagonist
12/09/2004US20040249153 For therapy of inflammation, rheumatoid arthritis, osteoarthritis, osteoporosis and tumors
12/09/2004US20040249138 for preparing Solanum alkaloid glycosides; Solanum is subjected to methanol extraction, drying the extract and dissolving in a weak volatile acid and centrifuged, the supernatant is precipitated using a volatile base; high purity
12/09/2004US20040249137 starage stable mixture of (7S,9S)-9-acetyl-9-amino-7-[(2S,4S,5R)-4,5-dihydroxyoxan-2-yl]oxy-6,11-dihydroxy-8,10-dihydro-7H-tetracene-5,12-dione hydrochloride and water, formed by blowing gases to control moisture content
12/09/2004US20040249133 Use of lipopeptides or lipoproteins for treating lung infections and lung tumours
12/09/2004US20040249132 Nuclear hormone receptor ligand binding domain
12/09/2004US20040249123 Nuclear receptor for use in identifying modulator for diagnosis, prevention and treatment of cell proliferative, blood, cardiovascular, skin, inflammatory, bone and nervous system disorders
12/09/2004US20040248986 Treating aggressive breast cancer with tesmilifene hydrochloride; synergistic effect combine with other chemotherapeutic agent like doxorubicin, taxanes